Drug Delivery In Cancer Market Size, Type Analysis, Application Analysis, End-Use, Industry Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2023-2032
- Report ID: ME_0077794
- Format: Electronic (PDF)
- Publish Type:
- Number of Pages: 250
Market Snapshot
CAGR:9.29
Source: Market Expertz
| Study Period | 2019-2032 |
| Base Year | 2023 |
| Forcast Year | 2023-2032 |
| CAGR | 9.29 |
Gain accurate insights regarding the negative impacts of COVID-19 on all markets and industries
Download Sample PdfReport Overview
In 2018, the global Drug Delivery in Cancer market size was xx million US$ and it is expected to reach xx million US$ by the end of 2026, with a CAGR of xx% during 2019-2026.This report focuses on the global Drug Delivery in Cancer status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Drug Delivery in Cancer development in United States, Europe and China.
The key players covered in this study
Amgen
Teva
UCB (Union Chimique Belge)
Roche
Celgene
Sanofi
Merck
Johnson & Johnson
Takeda
Gilead Sciences
Pfizer
Dr Reddy
Samyang Biopharmaceuticals
Tolmar
Astellas
AMAG Pharmaceuticals
AstraZeneca
AbbVie
Novartis
Aspen
Shire (Baxalta)
Breckenridge Pharmaceuticals
Galen Pharmaceuticals
Market segment by Type, the product can be split into
Liposomes
PEGylated Proteins & Polypeptides
Polymer Nanoparticle
Protein-drug Conjugates
Others
Market segment by Application, split into
Hospitals & Clinic
Cancer Treatment Centers
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Drug Delivery in Cancer status, future forecast, growth opportunity, key market and key players.
To present the Drug Delivery in Cancer development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Drug Delivery in Cancer are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2026
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Drug Delivery in Cancer Market Size Growth Rate by Type (2014-2025)
1.4.2 Liposomes
1.4.3 PEGylated Proteins & Polypeptides
1.4.4 Polymer Nanoparticle
1.4.5 Protein-drug Conjugates
1.4.6 Others
1.5 Market by Application
1.5.1 Global Drug Delivery in Cancer Market Share by Application (2014-2025)
1.5.2 Hospitals & Clinic
1.5.3 Cancer Treatment Centers
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Drug Delivery in Cancer Market Size
2.2 Drug Delivery in Cancer Growth Trends by Regions
2.2.1 Drug Delivery in Cancer Market Size by Regions (2014-2025)
2.2.2 Drug Delivery in Cancer Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Drug Delivery in Cancer Market Size by Manufacturers
3.1.1 Global Drug Delivery in Cancer Revenue by Manufacturers (2014-2019)
3.1.2 Global Drug Delivery in Cancer Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Drug Delivery in Cancer Market Concentration Ratio (CR5 and HHI)
3.2 Drug Delivery in Cancer Key Players Head office and Area Served
3.3 Key Players Drug Delivery in Cancer Product/Solution/Service
3.4 Date of Enter into Drug Delivery in Cancer Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Drug Delivery in Cancer Market Size by Type (2014-2019)
4.2 Global Drug Delivery in Cancer Market Size by Application (2014-2019)
5 United States
5.1 United States Drug Delivery in Cancer Market Size (2014-2019)
5.2 Drug Delivery in Cancer Key Players in United States
5.3 United States Drug Delivery in Cancer Market Size by Type
5.4 United States Drug Delivery in Cancer Market Size by Application
6 Europe
6.1 Europe Drug Delivery in Cancer Market Size (2014-2019)
6.2 Drug Delivery in Cancer Key Players in Europe
6.3 Europe Drug Delivery in Cancer Market Size by Type
6.4 Europe Drug Delivery in Cancer Market Size by Application
7 China
7.1 China Drug Delivery in Cancer Market Size (2014-2019)
7.2 Drug Delivery in Cancer Key Players in China
7.3 China Drug Delivery in Cancer Market Size by Type
7.4 China Drug Delivery in Cancer Market Size by Application
8 Japan
8.1 Japan Drug Delivery in Cancer Market Size (2014-2019)
8.2 Drug Delivery in Cancer Key Players in Japan
8.3 Japan Drug Delivery in Cancer Market Size by Type
8.4 Japan Drug Delivery in Cancer Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Drug Delivery in Cancer Market Size (2014-2019)
9.2 Drug Delivery in Cancer Key Players in Southeast Asia
9.3 Southeast Asia Drug Delivery in Cancer Market Size by Type
9.4 Southeast Asia Drug Delivery in Cancer Market Size by Application
10 India
10.1 India Drug Delivery in Cancer Market Size (2014-2019)
10.2 Drug Delivery in Cancer Key Players in India
10.3 India Drug Delivery in Cancer Market Size by Type
10.4 India Drug Delivery in Cancer Market Size by Application
11 Central & South America
11.1 Central & South America Drug Delivery in Cancer Market Size (2014-2019)
11.2 Drug Delivery in Cancer Key Players in Central & South America
11.3 Central & South America Drug Delivery in Cancer Market Size by Type
11.4 Central & South America Drug Delivery in Cancer Market Size by Application
12 International Players Profiles
12.1 Amgen
12.1.1 Amgen Company Details
12.1.2 Company Description and Business Overview
12.1.3 Drug Delivery in Cancer Introduction
12.1.4 Amgen Revenue in Drug Delivery in Cancer Business (2014-2019)
12.1.5 Amgen Recent Development
12.2 Teva
12.2.1 Teva Company Details
12.2.2 Company Description and Business Overview
12.2.3 Drug Delivery in Cancer Introduction
12.2.4 Teva Revenue in Drug Delivery in Cancer Business (2014-2019)
12.2.5 Teva Recent Development
12.3 UCB (Union Chimique Belge)
12.3.1 UCB (Union Chimique Belge) Company Details
12.3.2 Company Description and Business Overview
12.3.3 Drug Delivery in Cancer Introduction
12.3.4 UCB (Union Chimique Belge) Revenue in Drug Delivery in Cancer Business (2014-2019)
12.3.5 UCB (Union Chimique Belge) Recent Development
12.4 Roche
12.4.1 Roche Company Details
12.4.2 Company Description and Business Overview
12.4.3 Drug Delivery in Cancer Introduction
12.4.4 Roche Revenue in Drug Delivery in Cancer Business (2014-2019)
12.4.5 Roche Recent Development
12.5 Celgene
12.5.1 Celgene Company Details
12.5.2 Company Description and Business Overview
12.5.3 Drug Delivery in Cancer Introduction
12.5.4 Celgene Revenue in Drug Delivery in Cancer Business (2014-2019)
12.5.5 Celgene Recent Development
12.6 Sanofi
12.6.1 Sanofi Company Details
12.6.2 Company Description and Business Overview
12.6.3 Drug Delivery in Cancer Introduction
12.6.4 Sanofi Revenue in Drug Delivery in Cancer Business (2014-2019)
12.6.5 Sanofi Recent Development
12.7 Merck
12.7.1 Merck Company Details
12.7.2 Company Description and Business Overview
12.7.3 Drug Delivery in Cancer Introduction
12.7.4 Merck Revenue in Drug Delivery in Cancer Business (2014-2019)
12.7.5 Merck Recent Development
12.8 Johnson & Johnson
12.8.1 Johnson & Johnson Company Details
12.8.2 Company Description and Business Overview
12.8.3 Drug Delivery in Cancer Introduction
12.8.4 Johnson & Johnson Revenue in Drug Delivery in Cancer Business (2014-2019)
12.8.5 Johnson & Johnson Recent Development
12.9 Takeda
12.9.1 Takeda Company Details
12.9.2 Company Description and Business Overview
12.9.3 Drug Delivery in Cancer Introduction
12.9.4 Takeda Revenue in Drug Delivery in Cancer Business (2014-2019)
12.9.5 Takeda Recent Development
12.10 Gilead Sciences
12.10.1 Gilead Sciences Company Details
12.10.2 Company Description and Business Overview
12.10.3 Drug Delivery in Cancer Introduction
12.10.4 Gilead Sciences Revenue in Drug Delivery in Cancer Business (2014-2019)
12.10.5 Gilead Sciences Recent Development
12.11 Pfizer
12.12 Dr Reddy
12.13 Samyang Biopharmaceuticals
12.14 Tolmar
12.15 Astellas
12.16 AMAG Pharmaceuticals
12.17 AstraZeneca
12.18 AbbVie
12.19 Novartis
12.20 Aspen
12.21 Shire (Baxalta)
12.22 Breckenridge Pharmaceuticals
12.23 Galen Pharmaceuticals
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
Table Drug Delivery in Cancer Key Market Segments
Table Key Players Drug Delivery in Cancer Covered
Table Global Drug Delivery in Cancer Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Drug Delivery in Cancer Market Size Market Share by Type 2014-2025
Figure Liposomes Figures
Table Key Players of Liposomes
Figure PEGylated Proteins & Polypeptides Figures
Table Key Players of PEGylated Proteins & Polypeptides
Figure Polymer Nanoparticle Figures
Table Key Players of Polymer Nanoparticle
Figure Protein-drug Conjugates Figures
Table Key Players of Protein-drug Conjugates
Figure Others Figures
Table Key Players of Others
Table Global Drug Delivery in Cancer Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals & Clinic Case Studies
Figure Cancer Treatment Centers Case Studies
Figure Others Case Studies
Figure Drug Delivery in Cancer Report Years Considered
Table Global Drug Delivery in Cancer Market Size 2014-2025 (Million US$)
Figure Global Drug Delivery in Cancer Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Drug Delivery in Cancer Market Size by Regions 2014-2025 (Million US$)
Table Global Drug Delivery in Cancer Market Size by Regions 2014-2019 (Million US$)
Table Global Drug Delivery in Cancer Market Share by Regions 2014-2019
Figure Global Drug Delivery in Cancer Market Share by Regions 2014-2019
Figure Global Drug Delivery in Cancer Market Share by Regions 2019
Table Market Top Trends
Table Global Drug Delivery in Cancer Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Drug Delivery in Cancer Market Share by Manufacturers (2014-2019)
Figure Global Drug Delivery in Cancer Market Share by Manufacturers in 2018
Table Global Drug Delivery in Cancer Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Drug Delivery in Cancer Product/Solution/Service
Table Date of Enter into Drug Delivery in Cancer Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Drug Delivery in Cancer Market Size by Type (2014-2019) (Million US$)
Table Global Drug Delivery in Cancer Market Size Share by Type (2014-2019)
Figure Global Drug Delivery in Cancer Market Size Market Share by Type (2014-2019)
Table Global Drug Delivery in Cancer Market Size by Application (2014-2019) (Million US$)
Table Global Drug Delivery in Cancer Market Size Share by Application (2014-2019)
Figure Global Drug Delivery in Cancer Market Size Market Share by Application (2014-2019)
Figure Global Drug Delivery in Cancer Revenue Market Share by Application in 2018
Figure United States Drug Delivery in Cancer Market Size 2014-2019 (Million US$)
Table United States Key Players Drug Delivery in Cancer Revenue (2018-2019) (Million US$)
Table United States Key Players Drug Delivery in Cancer Market Share (2018-2019)
Table United States Drug Delivery in Cancer Market Size by Type (2014-2019) (Million US$)
Table United States Drug Delivery in Cancer Market Share by Type (2014-2019)
Table United States Drug Delivery in Cancer Market Size by Application (2014-2019) (Million US$)
Table United States Drug Delivery in Cancer Market Share by Application (2014-2019)
Figure Europe Drug Delivery in Cancer Market Size 2014-2019 (Million US$)
Table Europe Key Players Drug Delivery in Cancer Revenue (2018-2019) (Million US$)
Table Europe Key Players Drug Delivery in Cancer Market Share (2018-2019)
Table Europe Drug Delivery in Cancer Market Size by Type (2014-2019) (Million US$)
Table Europe Drug Delivery in Cancer Market Share by Type (2014-2019)
Table Europe Drug Delivery in Cancer Market Size by Application (2014-2019) (Million US$)
Table Europe Drug Delivery in Cancer Market Share by Application (2014-2019)
Figure China Drug Delivery in Cancer Market Size 2014-2019 (Million US$)
Table China Key Players Drug Delivery in Cancer Revenue (2018-2019) (Million US$)
Table China Key Players Drug Delivery in Cancer Market Share (2018-2019)
Table China Drug Delivery in Cancer Market Size by Type (2014-20189) (Million US$)
Table China Drug Delivery in Cancer Market Share by Type (2014-2019)
Table China Drug Delivery in Cancer Market Size by Application (2014-2019) (Million US$)
Table China Drug Delivery in Cancer Market Share by Application (2014-2019)
Figure Japan Drug Delivery in Cancer Market Size 2014-2019 (Million US$)
Table Japan Key Players Drug Delivery in Cancer Revenue (2018-2019) (Million US$)
Table Japan Key Players Drug Delivery in Cancer Market Share (2018-2019)
Table Japan Drug Delivery in Cancer Market Size by Type (2014-2019) (Million US$)
Table Japan Drug Delivery in Cancer Market Share by Type (2014-2019)
Table Japan Drug Delivery in Cancer Market Size by Application (2014-2019) (Million US$)
Table Japan Drug Delivery in Cancer Market Share by Application (2014-2019)
Figure Southeast Asia Drug Delivery in Cancer Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Drug Delivery in Cancer Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Drug Delivery in Cancer Market Share (2018-2019)
Table Southeast Asia Drug Delivery in Cancer Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Drug Delivery in Cancer Market Share by Type (2014-2019)
Table Southeast Asia Drug Delivery in Cancer Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Drug Delivery in Cancer Market Share by Application (2014-2019)
Figure India Drug Delivery in Cancer Market Size 2014-2019 (Million US$)
Table India Key Players Drug Delivery in Cancer Revenue (2018-2019) (Million US$)
Table India Key Players Drug Delivery in Cancer Market Share (2018-2019)
Table India Drug Delivery in Cancer Market Size by Type (2014-2019) (Million US$)
Table India Drug Delivery in Cancer Market Share by Type (2014-2019)
Table India Drug Delivery in Cancer Market Size by Application (2014-2019) (Million US$)
Table India Drug Delivery in Cancer Market Share by Application (2014-2019)
Figure Central & South America Drug Delivery in Cancer Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Drug Delivery in Cancer Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Drug Delivery in Cancer Market Share (2018-2019)
Table Central & South America Drug Delivery in Cancer Market Size by Type (2014-2019) (Million US$)
Table Central & South America Drug Delivery in Cancer Market Share by Type (2014-2019)
Table Central & South America Drug Delivery in Cancer Market Size by Application (2014-2019) (Million US$)
Table Central & South America Drug Delivery in Cancer Market Share by Application (2014-2019)
Table Amgen Company Details
Table Amgen Revenue in Drug Delivery in Cancer Business (2014-2019) (Million US$)
Figure Amgen Revenue Growth Rate in Drug Delivery in Cancer Business (2014-2019)
Table Amgen Recent Development
Table Teva Company Details
Table Teva Revenue in Drug Delivery in Cancer Business (2014-2019)(Million US$)
Figure Teva Revenue Growth Rate in Drug Delivery in Cancer Business (2014-2019)
Table Teva Recent Development
Table UCB (Union Chimique Belge) Company Details
Table UCB (Union Chimique Belge) Revenue in Drug Delivery in Cancer Business (2014-2019)(Million US$)
Figure UCB (Union Chimique Belge) Revenue Growth Rate in Drug Delivery in Cancer Business (2014-2019)
Table UCB (Union Chimique Belge) Recent Development
Table Roche Company Details
Table Roche Revenue in Drug Delivery in Cancer Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Drug Delivery in Cancer Business (2014-2019)
Table Roche Recent Development
Table Celgene Company Details
Table Celgene Revenue in Drug Delivery in Cancer Business (2014-2019)(Million US$)
Figure Celgene Revenue Growth Rate in Drug Delivery in Cancer Business (2014-2019)
Table Celgene Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Drug Delivery in Cancer Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Drug Delivery in Cancer Business (2014-2019)
Table Sanofi Recent Development
Table Merck Company Details
Table Merck Revenue in Drug Delivery in Cancer Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Drug Delivery in Cancer Business (2014-2019)
Table Merck Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Drug Delivery in Cancer Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Drug Delivery in Cancer Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Takeda Company Details
Table Takeda Revenue in Drug Delivery in Cancer Business (2014-2019)(Million US$)
Figure Takeda Revenue Growth Rate in Drug Delivery in Cancer Business (2014-2019)
Table Takeda Recent Development
Table Gilead Sciences Company Details
Table Gilead Sciences Revenue in Drug Delivery in Cancer Business (2014-2019)(Million US$)
Figure Gilead Sciences Revenue Growth Rate in Drug Delivery in Cancer Business (2014-2019)
Table Gilead Sciences Recent Development
Table Pfizer Company Details
Table Dr Reddy Company Details
Table Samyang Biopharmaceuticals Company Details
Table Tolmar Company Details
Table Astellas Company Details
Table AMAG Pharmaceuticals Company Details
Table AstraZeneca Company Details
Table AbbVie Company Details
Table Novartis Company Details
Table Aspen Company Details
Table Shire (Baxalta) Company Details
Table Breckenridge Pharmaceuticals Company Details
Table Galen Pharmaceuticals Company Details
Table Global Drug Delivery in Cancer Market Size by Regions (Million US$) 2019-2025
Figure Global Drug Delivery in Cancer Market Size Share by Regions (2019-2025)
Figure Global Drug Delivery in Cancer Market Size Share by Regions in 2025
Figure United States Drug Delivery in Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Europe Drug Delivery in Cancer Market Size Forecast (2019-2025)(Million USD)
Figure China Drug Delivery in Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Japan Drug Delivery in Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Drug Delivery in Cancer Market Size Forecast (2019-2025)(Million USD)
Figure India Drug Delivery in Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Drug Delivery in Cancer Market Size Forecast (2019-2025)(Million USD)
Table Global Drug Delivery in Cancer Market Size by Product (2019-2025) (Million US$)
Figure Global Drug Delivery in Cancer Market Size by Product (2019-2025)
Figure Global Drug Delivery in Cancer Market Size by Product in 2025
Table Global Drug Delivery in Cancer Market Size by Application (2019-2025) (Million US$)
Figure Global Drug Delivery in Cancer Market Size by Application (2019-2025)
Figure Global Drug Delivery in Cancer Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Drug Delivery in Cancer Market Size Growth Rate by Type (2014-2025)
1.4.2 Liposomes
1.4.3 PEGylated Proteins & Polypeptides
1.4.4 Polymer Nanoparticle
1.4.5 Protein-drug Conjugates
1.4.6 Others
1.5 Market by Application
1.5.1 Global Drug Delivery in Cancer Market Share by Application (2014-2025)
1.5.2 Hospitals & Clinic
1.5.3 Cancer Treatment Centers
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Drug Delivery in Cancer Market Size
2.2 Drug Delivery in Cancer Growth Trends by Regions
2.2.1 Drug Delivery in Cancer Market Size by Regions (2014-2025)
2.2.2 Drug Delivery in Cancer Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Drug Delivery in Cancer Market Size by Manufacturers
3.1.1 Global Drug Delivery in Cancer Revenue by Manufacturers (2014-2019)
3.1.2 Global Drug Delivery in Cancer Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Drug Delivery in Cancer Market Concentration Ratio (CR5 and HHI)
3.2 Drug Delivery in Cancer Key Players Head office and Area Served
3.3 Key Players Drug Delivery in Cancer Product/Solution/Service
3.4 Date of Enter into Drug Delivery in Cancer Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Drug Delivery in Cancer Market Size by Type (2014-2019)
4.2 Global Drug Delivery in Cancer Market Size by Application (2014-2019)
5 United States
5.1 United States Drug Delivery in Cancer Market Size (2014-2019)
5.2 Drug Delivery in Cancer Key Players in United States
5.3 United States Drug Delivery in Cancer Market Size by Type
5.4 United States Drug Delivery in Cancer Market Size by Application
6 Europe
6.1 Europe Drug Delivery in Cancer Market Size (2014-2019)
6.2 Drug Delivery in Cancer Key Players in Europe
6.3 Europe Drug Delivery in Cancer Market Size by Type
6.4 Europe Drug Delivery in Cancer Market Size by Application
7 China
7.1 China Drug Delivery in Cancer Market Size (2014-2019)
7.2 Drug Delivery in Cancer Key Players in China
7.3 China Drug Delivery in Cancer Market Size by Type
7.4 China Drug Delivery in Cancer Market Size by Application
8 Japan
8.1 Japan Drug Delivery in Cancer Market Size (2014-2019)
8.2 Drug Delivery in Cancer Key Players in Japan
8.3 Japan Drug Delivery in Cancer Market Size by Type
8.4 Japan Drug Delivery in Cancer Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Drug Delivery in Cancer Market Size (2014-2019)
9.2 Drug Delivery in Cancer Key Players in Southeast Asia
9.3 Southeast Asia Drug Delivery in Cancer Market Size by Type
9.4 Southeast Asia Drug Delivery in Cancer Market Size by Application
10 India
10.1 India Drug Delivery in Cancer Market Size (2014-2019)
10.2 Drug Delivery in Cancer Key Players in India
10.3 India Drug Delivery in Cancer Market Size by Type
10.4 India Drug Delivery in Cancer Market Size by Application
11 Central & South America
11.1 Central & South America Drug Delivery in Cancer Market Size (2014-2019)
11.2 Drug Delivery in Cancer Key Players in Central & South America
11.3 Central & South America Drug Delivery in Cancer Market Size by Type
11.4 Central & South America Drug Delivery in Cancer Market Size by Application
12 International Players Profiles
12.1 Amgen
12.1.1 Amgen Company Details
12.1.2 Company Description and Business Overview
12.1.3 Drug Delivery in Cancer Introduction
12.1.4 Amgen Revenue in Drug Delivery in Cancer Business (2014-2019)
12.1.5 Amgen Recent Development
12.2 Teva
12.2.1 Teva Company Details
12.2.2 Company Description and Business Overview
12.2.3 Drug Delivery in Cancer Introduction
12.2.4 Teva Revenue in Drug Delivery in Cancer Business (2014-2019)
12.2.5 Teva Recent Development
12.3 UCB (Union Chimique Belge)
12.3.1 UCB (Union Chimique Belge) Company Details
12.3.2 Company Description and Business Overview
12.3.3 Drug Delivery in Cancer Introduction
12.3.4 UCB (Union Chimique Belge) Revenue in Drug Delivery in Cancer Business (2014-2019)
12.3.5 UCB (Union Chimique Belge) Recent Development
12.4 Roche
12.4.1 Roche Company Details
12.4.2 Company Description and Business Overview
12.4.3 Drug Delivery in Cancer Introduction
12.4.4 Roche Revenue in Drug Delivery in Cancer Business (2014-2019)
12.4.5 Roche Recent Development
12.5 Celgene
12.5.1 Celgene Company Details
12.5.2 Company Description and Business Overview
12.5.3 Drug Delivery in Cancer Introduction
12.5.4 Celgene Revenue in Drug Delivery in Cancer Business (2014-2019)
12.5.5 Celgene Recent Development
12.6 Sanofi
12.6.1 Sanofi Company Details
12.6.2 Company Description and Business Overview
12.6.3 Drug Delivery in Cancer Introduction
12.6.4 Sanofi Revenue in Drug Delivery in Cancer Business (2014-2019)
12.6.5 Sanofi Recent Development
12.7 Merck
12.7.1 Merck Company Details
12.7.2 Company Description and Business Overview
12.7.3 Drug Delivery in Cancer Introduction
12.7.4 Merck Revenue in Drug Delivery in Cancer Business (2014-2019)
12.7.5 Merck Recent Development
12.8 Johnson & Johnson
12.8.1 Johnson & Johnson Company Details
12.8.2 Company Description and Business Overview
12.8.3 Drug Delivery in Cancer Introduction
12.8.4 Johnson & Johnson Revenue in Drug Delivery in Cancer Business (2014-2019)
12.8.5 Johnson & Johnson Recent Development
12.9 Takeda
12.9.1 Takeda Company Details
12.9.2 Company Description and Business Overview
12.9.3 Drug Delivery in Cancer Introduction
12.9.4 Takeda Revenue in Drug Delivery in Cancer Business (2014-2019)
12.9.5 Takeda Recent Development
12.10 Gilead Sciences
12.10.1 Gilead Sciences Company Details
12.10.2 Company Description and Business Overview
12.10.3 Drug Delivery in Cancer Introduction
12.10.4 Gilead Sciences Revenue in Drug Delivery in Cancer Business (2014-2019)
12.10.5 Gilead Sciences Recent Development
12.11 Pfizer
12.12 Dr Reddy
12.13 Samyang Biopharmaceuticals
12.14 Tolmar
12.15 Astellas
12.16 AMAG Pharmaceuticals
12.17 AstraZeneca
12.18 AbbVie
12.19 Novartis
12.20 Aspen
12.21 Shire (Baxalta)
12.22 Breckenridge Pharmaceuticals
12.23 Galen Pharmaceuticals
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
Table Drug Delivery in Cancer Key Market Segments
Table Key Players Drug Delivery in Cancer Covered
Table Global Drug Delivery in Cancer Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Drug Delivery in Cancer Market Size Market Share by Type 2014-2025
Figure Liposomes Figures
Table Key Players of Liposomes
Figure PEGylated Proteins & Polypeptides Figures
Table Key Players of PEGylated Proteins & Polypeptides
Figure Polymer Nanoparticle Figures
Table Key Players of Polymer Nanoparticle
Figure Protein-drug Conjugates Figures
Table Key Players of Protein-drug Conjugates
Figure Others Figures
Table Key Players of Others
Table Global Drug Delivery in Cancer Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals & Clinic Case Studies
Figure Cancer Treatment Centers Case Studies
Figure Others Case Studies
Figure Drug Delivery in Cancer Report Years Considered
Table Global Drug Delivery in Cancer Market Size 2014-2025 (Million US$)
Figure Global Drug Delivery in Cancer Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Drug Delivery in Cancer Market Size by Regions 2014-2025 (Million US$)
Table Global Drug Delivery in Cancer Market Size by Regions 2014-2019 (Million US$)
Table Global Drug Delivery in Cancer Market Share by Regions 2014-2019
Figure Global Drug Delivery in Cancer Market Share by Regions 2014-2019
Figure Global Drug Delivery in Cancer Market Share by Regions 2019
Table Market Top Trends
Table Global Drug Delivery in Cancer Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Drug Delivery in Cancer Market Share by Manufacturers (2014-2019)
Figure Global Drug Delivery in Cancer Market Share by Manufacturers in 2018
Table Global Drug Delivery in Cancer Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Drug Delivery in Cancer Product/Solution/Service
Table Date of Enter into Drug Delivery in Cancer Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Drug Delivery in Cancer Market Size by Type (2014-2019) (Million US$)
Table Global Drug Delivery in Cancer Market Size Share by Type (2014-2019)
Figure Global Drug Delivery in Cancer Market Size Market Share by Type (2014-2019)
Table Global Drug Delivery in Cancer Market Size by Application (2014-2019) (Million US$)
Table Global Drug Delivery in Cancer Market Size Share by Application (2014-2019)
Figure Global Drug Delivery in Cancer Market Size Market Share by Application (2014-2019)
Figure Global Drug Delivery in Cancer Revenue Market Share by Application in 2018
Figure United States Drug Delivery in Cancer Market Size 2014-2019 (Million US$)
Table United States Key Players Drug Delivery in Cancer Revenue (2018-2019) (Million US$)
Table United States Key Players Drug Delivery in Cancer Market Share (2018-2019)
Table United States Drug Delivery in Cancer Market Size by Type (2014-2019) (Million US$)
Table United States Drug Delivery in Cancer Market Share by Type (2014-2019)
Table United States Drug Delivery in Cancer Market Size by Application (2014-2019) (Million US$)
Table United States Drug Delivery in Cancer Market Share by Application (2014-2019)
Figure Europe Drug Delivery in Cancer Market Size 2014-2019 (Million US$)
Table Europe Key Players Drug Delivery in Cancer Revenue (2018-2019) (Million US$)
Table Europe Key Players Drug Delivery in Cancer Market Share (2018-2019)
Table Europe Drug Delivery in Cancer Market Size by Type (2014-2019) (Million US$)
Table Europe Drug Delivery in Cancer Market Share by Type (2014-2019)
Table Europe Drug Delivery in Cancer Market Size by Application (2014-2019) (Million US$)
Table Europe Drug Delivery in Cancer Market Share by Application (2014-2019)
Figure China Drug Delivery in Cancer Market Size 2014-2019 (Million US$)
Table China Key Players Drug Delivery in Cancer Revenue (2018-2019) (Million US$)
Table China Key Players Drug Delivery in Cancer Market Share (2018-2019)
Table China Drug Delivery in Cancer Market Size by Type (2014-20189) (Million US$)
Table China Drug Delivery in Cancer Market Share by Type (2014-2019)
Table China Drug Delivery in Cancer Market Size by Application (2014-2019) (Million US$)
Table China Drug Delivery in Cancer Market Share by Application (2014-2019)
Figure Japan Drug Delivery in Cancer Market Size 2014-2019 (Million US$)
Table Japan Key Players Drug Delivery in Cancer Revenue (2018-2019) (Million US$)
Table Japan Key Players Drug Delivery in Cancer Market Share (2018-2019)
Table Japan Drug Delivery in Cancer Market Size by Type (2014-2019) (Million US$)
Table Japan Drug Delivery in Cancer Market Share by Type (2014-2019)
Table Japan Drug Delivery in Cancer Market Size by Application (2014-2019) (Million US$)
Table Japan Drug Delivery in Cancer Market Share by Application (2014-2019)
Figure Southeast Asia Drug Delivery in Cancer Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Drug Delivery in Cancer Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Drug Delivery in Cancer Market Share (2018-2019)
Table Southeast Asia Drug Delivery in Cancer Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Drug Delivery in Cancer Market Share by Type (2014-2019)
Table Southeast Asia Drug Delivery in Cancer Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Drug Delivery in Cancer Market Share by Application (2014-2019)
Figure India Drug Delivery in Cancer Market Size 2014-2019 (Million US$)
Table India Key Players Drug Delivery in Cancer Revenue (2018-2019) (Million US$)
Table India Key Players Drug Delivery in Cancer Market Share (2018-2019)
Table India Drug Delivery in Cancer Market Size by Type (2014-2019) (Million US$)
Table India Drug Delivery in Cancer Market Share by Type (2014-2019)
Table India Drug Delivery in Cancer Market Size by Application (2014-2019) (Million US$)
Table India Drug Delivery in Cancer Market Share by Application (2014-2019)
Figure Central & South America Drug Delivery in Cancer Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Drug Delivery in Cancer Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Drug Delivery in Cancer Market Share (2018-2019)
Table Central & South America Drug Delivery in Cancer Market Size by Type (2014-2019) (Million US$)
Table Central & South America Drug Delivery in Cancer Market Share by Type (2014-2019)
Table Central & South America Drug Delivery in Cancer Market Size by Application (2014-2019) (Million US$)
Table Central & South America Drug Delivery in Cancer Market Share by Application (2014-2019)
Table Amgen Company Details
Table Amgen Revenue in Drug Delivery in Cancer Business (2014-2019) (Million US$)
Figure Amgen Revenue Growth Rate in Drug Delivery in Cancer Business (2014-2019)
Table Amgen Recent Development
Table Teva Company Details
Table Teva Revenue in Drug Delivery in Cancer Business (2014-2019)(Million US$)
Figure Teva Revenue Growth Rate in Drug Delivery in Cancer Business (2014-2019)
Table Teva Recent Development
Table UCB (Union Chimique Belge) Company Details
Table UCB (Union Chimique Belge) Revenue in Drug Delivery in Cancer Business (2014-2019)(Million US$)
Figure UCB (Union Chimique Belge) Revenue Growth Rate in Drug Delivery in Cancer Business (2014-2019)
Table UCB (Union Chimique Belge) Recent Development
Table Roche Company Details
Table Roche Revenue in Drug Delivery in Cancer Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Drug Delivery in Cancer Business (2014-2019)
Table Roche Recent Development
Table Celgene Company Details
Table Celgene Revenue in Drug Delivery in Cancer Business (2014-2019)(Million US$)
Figure Celgene Revenue Growth Rate in Drug Delivery in Cancer Business (2014-2019)
Table Celgene Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Drug Delivery in Cancer Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Drug Delivery in Cancer Business (2014-2019)
Table Sanofi Recent Development
Table Merck Company Details
Table Merck Revenue in Drug Delivery in Cancer Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Drug Delivery in Cancer Business (2014-2019)
Table Merck Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Drug Delivery in Cancer Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Drug Delivery in Cancer Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Takeda Company Details
Table Takeda Revenue in Drug Delivery in Cancer Business (2014-2019)(Million US$)
Figure Takeda Revenue Growth Rate in Drug Delivery in Cancer Business (2014-2019)
Table Takeda Recent Development
Table Gilead Sciences Company Details
Table Gilead Sciences Revenue in Drug Delivery in Cancer Business (2014-2019)(Million US$)
Figure Gilead Sciences Revenue Growth Rate in Drug Delivery in Cancer Business (2014-2019)
Table Gilead Sciences Recent Development
Table Pfizer Company Details
Table Dr Reddy Company Details
Table Samyang Biopharmaceuticals Company Details
Table Tolmar Company Details
Table Astellas Company Details
Table AMAG Pharmaceuticals Company Details
Table AstraZeneca Company Details
Table AbbVie Company Details
Table Novartis Company Details
Table Aspen Company Details
Table Shire (Baxalta) Company Details
Table Breckenridge Pharmaceuticals Company Details
Table Galen Pharmaceuticals Company Details
Table Global Drug Delivery in Cancer Market Size by Regions (Million US$) 2019-2025
Figure Global Drug Delivery in Cancer Market Size Share by Regions (2019-2025)
Figure Global Drug Delivery in Cancer Market Size Share by Regions in 2025
Figure United States Drug Delivery in Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Europe Drug Delivery in Cancer Market Size Forecast (2019-2025)(Million USD)
Figure China Drug Delivery in Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Japan Drug Delivery in Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Drug Delivery in Cancer Market Size Forecast (2019-2025)(Million USD)
Figure India Drug Delivery in Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Drug Delivery in Cancer Market Size Forecast (2019-2025)(Million USD)
Table Global Drug Delivery in Cancer Market Size by Product (2019-2025) (Million US$)
Figure Global Drug Delivery in Cancer Market Size by Product (2019-2025)
Figure Global Drug Delivery in Cancer Market Size by Product in 2025
Table Global Drug Delivery in Cancer Market Size by Application (2019-2025) (Million US$)
Figure Global Drug Delivery in Cancer Market Size by Application (2019-2025)
Figure Global Drug Delivery in Cancer Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
RESEARCH METHODOLOGY
A research methodology is a systematic approach for assessing or conducting a market study. Researchers tend to draw on a variety of both qualitative and quantitative study methods, inclusive of investigations, survey, secondary data and market observation.
Such plans can focus on classifying the products offered by leading market players or simply use statistical models to interpret observations or test hypotheses. While some methods aim for a detailed description of the factors behind an observation, others present the context of the current market scenario.
Now let’s take a closer look at the research methods here.
Secondary Research Model
Extensive data is obtained and cumulated on a substantial basis during the inception phase of the research process. The data accumulated is consistently filtered through validation from the in-house database, paid sources as well reputable industry magazines. A robust research study requires an understanding of the overall value chain. Annual reports and financials of industry players are studied thoroughly to have a comprehensive idea of the market taxonomy.
Primary Insights
Post conglomeration of the data obtained through secondary research; a validation process is initiated to verify the numbers or figures. This process is usually performed by having a detailed discussion with the industry experts.
However, we do not restrict our primary interviews only to the industry leaders. Our team covers the entire value chain while verifying the data. A significant number of raw material suppliers, local manufacturers, distributors, and stakeholders are interviewed to make our findings authentic. The current trends which include the drivers, restraints, and opportunities are also derived through the primary research process.
Market Estimation
The market estimation is conducted by analyzing the data collected through both secondary and primary research. This process involves market breakdown, bottom-up and top- down approach.
Moreover, while forecasting the market a comprehensive statistical time series model is designed for each market. Macroeconomic indicators are considered to understand the current trends of the market. Each data point is verified by the process of data triangulation method to arrive at the final market estimates.
Final Presentation
The penultimate process results in a holistic research report. The study equips key industry players to undertake significant strategic decisions through the findings. The report encompasses detailed market information. Graphical representations of the current market trends are also made available in order to make the study highly comprehensible for the reader.
You can also purchase parts of this report. Do you want to check out a section wise price list?
Personalized Business Report Tailored to Your Requirements
- Our expert analysts collaborate directly with you to comprehend your specific needs.
- Get data on regions, segments, competitors, and vendors of your choice.
- Information is presented in alignment with your exact preferences and formatting.
Free Sample Report
"Find new revenue generation opportunities"